The "Invitation" fromε₹• Haibu Pharmaceuticalα×↓ invites you to gathe¥¶≤r in Beijing for the [P€₩↕harmaceutical CXO + MAH Trading a®§♠nd Matching Expo] on Octoβ♣©πber 19-20, 2023.

Beijing Haibu Pharmaceutical T×≥γαechnology Co., Ltd. (referrΩ↑Ωεed to as "Haibu Pharmaceutical") was ♣γ established in 2005 and®∑ is a high-tech enterprise with ☆£δ"chemical drug research and developφ£÷ment" as its core capability. It has a ‍↕research and development center ✔♠♣©in Beijing, a pilot ver$₩ification center for raw materials and←★φ♥ formulations, and a GMP industrial prΩ↔oduction base, mainly engaged in CRO ≥•services for raw materials and formulat♦®≠¶ions, MAH joint licensing, related app≥↔∞lications for raw mat‌​<₽erials, and commercial supp≤₽ly of pharmaceutical intermediates.It has rich experience&₩≥ in the research and production tra→σ£nsfer, registration applic♠&©"ation, etc., of various dosage forms≠£ such as chemical raw mater¥ε®↑ials, oral solids, liquid preparations​≤§<, sterile injections, and external π≥preparations. The R&am↑§p;D products cover multiΩ•γ•ple therapeutic areas incl☆£uding anti-tumor, anti-depressi>"≈ on, anti-epilepsy, ant‍✘i-anxiety, cardiovascular and cerebr¥‌ ovascular diseases, digestπ ∞♣ive system disorders, respiratory ¥™±system issues, etc.

Haibu Pharmaceutical ha☆‌s been awarded the title of "Top ★♥¶♦20 Pharmaceutical R&D Compani∏±Ωes in China" for several consecutive‌γ∏∞ years and has been recognized as a "Sp ∞"ecialized and Innovative" eφ÷↕nterprise in Beijing, a "National High§♠-tech Enterprise", a "Be←•∏ijing Science and Technology"€ Research Development Ins←™titution", and a "Beiε"₹Ωjing Yizhuang Enterprise Innov∏↕ation Center", among others.